淋病奈瑟菌疫苗影响的数学模型综述:对疫苗研发的启示
本综述梳理了淋病奈瑟菌疫苗数学建模研究的关键方面,包括模型结构、考虑人群、假设、疫苗特性及实施场景。不同研究预测的疫苗影响差异较大,30年后淋病奈瑟菌患病率降低约17%至5年后降低100%不等,但所有研究均预测即使部分有效的疫苗在高覆盖率下也能大幅降低患病率或发病率。
要点
- 不同模型预测疫苗影响差异大:30年患病率降低约17%至5年降低100%。
- 即使部分有效的疫苗,在高覆盖率下对高风险人群或性活跃人群也有实质性影响。
- 未来建模应关注中低收入地区高风险人群及感染的不良性健康与生殖健康结局。
核心结论
- 所有研究预测即使部分有效的淋病疫苗在高覆盖率下对降低淋病奈瑟菌患病率或发病率也有实质性影响。
- 疫苗对预防淋病奈瑟菌感染的效力越高、保护持续时间越长,感染下降幅度越大。
- 能改变继续传播的疫苗也可大幅减少感染。
研究设计与样本
- 本综述为叙述性文献综述,系统梳理了淋病奈瑟菌疫苗数学建模研究的关键方面。
- 综述内容包括模型结构、考虑人群、假设、疫苗特性及实施场景。
主要发现
- 不同研究预测的疫苗影响差异较大,范围从30年后淋病奈瑟菌患病率降低约17%至5年后降低100%。
- 所有研究均预测即使部分有效的疫苗在高覆盖率下对高风险人群或整体性活跃人群也有实质性影响。
- 疫苗对预防淋病奈瑟菌感染的效力越高及保护持续时间越长,与更大的感染下降相关。
- 能改变继续传播的疫苗也可大幅减少感染。
关键数值与推荐
- 预测的疫苗影响范围:30年后淋病奈瑟菌患病率降低约17%至5年后降低100%。
- 所有研究预测即使部分有效的疫苗在高覆盖率下也有实质性影响。
临床怎么用
- 未来建模应纳入中低收入地区等淋病奈瑟菌感染高风险人群。
- 未来建模应考虑疫苗接种对感染潜在不良性健康与生殖健康结局的影响。
- 需更详细稳健的流行病学、生物学和行为数据以进行更准确稳健的建模,为科学和公共卫生决策提供信息。
局限性
- 不同研究预测的疫苗影响差异较大,范围从30年后患病率降低约17%至5年后降低100%。
- 研究人员通过本叙述性文献综述指出了若干空白和研究需求。
- 未来建模应考虑额外的高风险人群,尤其是中低收入地区。
- 需更详细稳健的流行病学、生物学和行为数据以支持更准确稳健的建模。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An effective prophylactic vaccine for prevention of Neisseria gonorrhoeae infection would have a major impact on sexual and reproductive health worldwide. Interest in developing gonorrhoea vaccines is growing due to the reported high rates of N. gonorrhoeae infections globally, and the threat of antimicrobial resistance. Several gonorrhoea vaccine candidates are currently under evaluation and various mathematical models have been used to assess the potential population-level impact a gonorrhoea vaccine may have once available. Here we review key aspects of gonorrhoea vaccine mathematical modelling studies, including model structures, populations considered, and assumptions used as well as vaccine characteristics and implementation scenarios investigated. The predicted vaccine impact varied between studies, ranging from as little as ∼17 % reduction in N. gonorrhoeae prevalence after 30 years up to 100 % reduction after 5 years. However, all studies predicted that even a partially effective gonorrhoea vaccine could have a substantial impact in reducing N. gonorrhoeae prevalence or incidence, particularly when high coverage is achieved within either important risk groups or the overall sexually active population. As expected, higher vaccine efficacy against acquisition of N. gonorrhoeae and longer duration of protection were linked to greater reductions in infections. A vaccine that alters onward transmission could also substantially reduce infections. Several gaps and research needs have been identified by researchers in the field and via this narrative literature review. For example, future modelling to inform gonorrhoea vaccine development and implementation should consider additional populations that are at high risk of N. gonorrhoeae infection, especially in low- and middle-income settings, as well as the impact of vaccination on the potential adverse sexual and reproductive health outcomes of infection. In addition, more detailed and robust epidemiological, biological, and behavioural data is needed to enable more accurate and robust modelling of gonorrhoea vaccine impact to inform future scientific and public health decision-making.
引用
- Padeniya TN, Hui BB, Wood JG, et al. Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development. Vaccine. 2024. PMID: 38556390. doi:10.1016/j.vaccine.2024.03.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。